Literature DB >> 10432526

A multidisciplinary approach to atypical lacrimal obstruction in childhood.

J F Wong1, J J Woog, M J Cunningham, P A Rubin, H D Curtin, B L Carter.   

Abstract

PURPOSE: This study explores the diagnosis and management of unusual anomalies involving the canaliculi, nasolacrimal duct, nasal cavity, and sinuses in childhood.
METHODS: A case series of eight children with lacrimal outflow anomalies ranging from distal nasolacrimal duct cyst formation to persistent dacryocystitis following failed probing or silicone intubation were reviewed retrospectively. Diagnostic studies including intranasal endoscopy and preoperative or intraoperative dacryocystography (DCG) were of value.
RESULTS: Treatment modalities included endoscopically guided resection of lacrimal cyst mucosa, endoscopic dacryocystorhinostomy (DCR), and monocanalicular or bicanalicular intubation of the lacrimal outflow system. In our series, endoscopic surgery was well tolerated by all patients with improvement in symptoms.
CONCLUSIONS: This initial experience suggests that endoscopic techniques may be useful in the management of atypical lacrimal outflow obstruction in childhood.

Entities:  

Mesh:

Year:  1999        PMID: 10432526     DOI: 10.1097/00002341-199907000-00011

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Dacryocystorhinostomy: History, evolution and future directions.

Authors:  Vladimir S Yakopson; Joseph C Flanagan; Daniel Ahn; Betsy P Luo
Journal:  Saudi J Ophthalmol       Date:  2010-10-18

2.  The association of neonatal dacryocystoceles and infantile dacryocystitis with nasolacrimal duct cysts (an American Ophthalmological Society thesis).

Authors:  Gregg T Lueder
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

3.  Congenital nasolacrimal duct cyst/dacryocystocele: An argument for a genetic basis.

Authors:  Henry P Barham; Justin M Wudel; Robert W Enzenauer; Kenny H Chan
Journal:  Allergy Rhinol (Providence)       Date:  2012-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.